Comparing temporal profiles in type 2 diabetes patients who achieve target HbA1c following initiation of basal insulin

被引：0
|
作者：
Ling, J. [1 ]
Ozaki, R. [2 ]
Luk, A. [1 ]
Chan, J. C. N. [1 ]
Chow, E. [1 ]
机构：
[1] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China
[2] Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Peoples R China
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2023年 / 197卷
关键词：
D O I：
10.1016/j.diabres.2023.110302
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
IDF2022-03
引用
收藏
页数：2
相关论文
共 50 条
  • [31] The PREFER study:: both biphasic insulin aspart 30 twice-daily and basal-bolus using insulin detemir and insulin aspart enabled patients with type 2 diabetes to achieve HbA1c target<7.0%
    Liebl, A.
    Prager, R.
    Kaiser, M.
    Binz, K.
    Gailwitz, B.
    DIABETOLOGIA, 2006, 49 : 610 - 611
  • [32] The relationship of HbA1c and weight in the treatment of patients with type 2 diabetes
    Mathisen, AL
    Brockley, MR
    DIABETES, 2000, 49 : A117 - A117
  • [33] Mean HbA1c and HbA1c variability are associated with differing diabetes-related complications in patients with type 2 diabetes mellitus
    Wu, Tzu-En
    Su, Yu-Wen
    Chen, Harn-Shen
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 192
  • [34] Predictors of worsening of glycemic control in patients with type 2 diabetes mellitus not on insulin and with HbA1c≤ 7.0%
    De Valk, HW
    Van Dillen, MEL
    Chorus, RCH
    De Bruin, HJ
    Erkelens, DW
    DIABETES, 2001, 50 : A109 - A110
  • [35] Impact of treatment persistence on glycated haemoglobin A1c (HbA1c) trends among patients with type 2 diabetes newly initiated on basal insulin
    Xie, L.
    Zhou, F. L.
    Pan, C.
    Vaidya, N.
    Ye, F.
    Preblick, R.
    Meneghini, L.
    DIABETOLOGIA, 2017, 60 : S309 - S309
  • [36] Pramlintide, as an adjunct to premixed insulin, reduced HbA1c and body weight in patients with type 2 diabetes
    Darsow, T.
    Lorenzi, G.
    Zhang, B.
    Maier, H.
    Wilhelm, K.
    DIABETOLOGIA, 2008, 51 : S409 - S409
  • [37] Basal insulin peglispro is superior to insulin glargine in reducing HbA1c in insulin-naive patients with type 2 diabetes treated with oral antihyperglycaemic drugs: IMAGINE 2
    Davies, M. J.
    Russell-Jones, D.
    Selam, J. -L.
    Bailey, T. S.
    Kerenyi, Z.
    Luo, J.
    Bue-Valleskey, J.
    Ivanyi, T.
    Hartman, M. L.
    Jacobson, J. G.
    Jacober, S. J.
    DIABETOLOGIA, 2015, 58 : S19 - S20
  • [38] Effect of orlistat on insulin resistance in patients with type 2 diabetes with baseline HbA1c levels ≥8%
    Rissanen, A
    Hollander, P
    DIABETES, 2002, 51 : A413 - A413
  • [39] Interpersonal predictors of HbA1c in patients with type 1 diabetes
    Ciechanowski, PS
    Hirsch, IB
    Katon, WJ
    DIABETES CARE, 2002, 25 (04) : 731 - 736
  • [40] Interpersonal predictors of HbA1c in patients with type 1 diabetes
    Ciechanowski, PS
    Hirsch, IB
    Katon, WJ
    DIABETES, 2001, 50 : A48 - A48
12345